bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer

Applied Immunohistochemistry and Molecular Morphology

Volumn 9, Issue 4, 2001, Pages 329-334

  Scopa, C D ^a   Vagianos, C ^a   Kardamakis, D ^a   Kourelis, T G ^a   Kalofonos, H P ^a   Tsamandas, A C ^a  

^a NONE   (Greece)

Author keywords

Bax; bcl 2; Colon cancer; Immunohistochemistry; Radiotherapy; Rectum

Indexed keywords

BIOLOGICAL MARKER; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; PROTEIN BAX; PROTEIN BCL 2; ONCOPROTEIN; PROTO ONCOGENE PROTEINS; PROTO ONCOGENE PROTEINS C BCL 2;

APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COLON RESECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RECTUM CANCER; ADENOCARCINOMA; ADJUVANT THERAPY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RECTUM TUMOR; STANDARD; TREATMENT FAILURE;

ADENOCARCINOMA; BIOLOGICAL MARKERS; COMBINED MODALITY THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT FAILURE;

EID: 0035192977     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200112000-00007     Document Type: Article

References (53)

1. Gastrointestinal tract: Large bowel
2. Colon, rectum and anus
3. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid
4. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01
5. Radiation theraphy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum
6. Apoptosis and the dilemma of cancer chemotherapy
7. Apoptosis
8. Apoptosis: Pathophysiology of programmed cell death
9. Apoptosis: Its significance in cancer and cancer therapy
10. Apoptosis in irradiated murine tumors
11. Spontaneous and radiation-induced apoptosis in lung carcinoma cells with different intrinsic radiosensitivities
12. bcl-2/bax ratio as a predictive a marker for therapeutic response to radiotherapy in patients with prostate cancer
13. bcl-2 overexpression delays radiation induced apoptosis without affecting the clonogenic survival of human prostate cancer cells
14. Nucleotide sequence of a t (14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a break-point cluster region near a transcriptionally active locus on chromosome 18
15. bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death
16. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
17. Investigations of subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes
18. bcl-2 and the regulation of programmed cell death
19. Histopathological evaluation of apoptosis in cancer
20. Expression of the human bcl-2 transgene increases the radiation resistance of a hematopoietic progenitor cell line
21. Expression of bcl-2 predicts efficacy of adjuvant treatments in operable node-positive breast cancer
22. Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy
23. bcl-2 heterodimerizes in vivo with a conserved homologue BAX that accelerates cell death
24. Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis
25. The potential role of bcl-2, p53 and bax expression in rectal adenocarcinoma and their correlation with tumor prognosis
26. The prognostic significance of direct extention of carcinoma of the colon and rectum
27. Preoperative chemotherapy induces apoptosis in early breast cancer
28. bax and bcl-2 expression predict response to radiotherapy in human cervical cancer
29. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma
30. bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical carcinoma
31. bcl-2 expression, p53 accumulation and apoptosis in ovarian carcinomas
32. bcl-2 protein in non-small-cell lung carcinoma
33. Prognostic significance of bcl-2 in clinically localized prostate cancer
34. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix
35. Prognostic significance of MIB-1, p53 and bcl-2 immunoreactivity in meningiomas
36. Apoptosis, cell proliferation and expression of bcl-2 and bax in gastric carcinomas: Immunohistochemical and clinicopathological study
37. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death
38. Structure and function of the p53 tumor suppressor gene: Clues for rationale cancer therapeutic strategies
39. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents
40. The bax: Bcl-2 ratio modulates the response to dexamethasone in leukemic cells and is highly variable in childhood acute leukemia
41. bcl-2/bax ratios in chronic lymphocytic leukemia and their correlation with in vitro apoptosis and clinical resistance
42. BH1 and BH2 domains of bcl-2, are required for inhibition of apoptosis and heterodimerization with bax
43. Radiation induces upregulation of bax protein and apoptosis in radiosensitive cells in vivo
44. Inhibition of bax channel-forming activity for bcl-2
45. Conversion of bcl-2 to a bax-like death effector by caspases
46. Role of bcl-1 family proteins (bax, bcl-2 and bcl-x) on cellular susceptibility to radiation in pancreatic cancer cells
47. Immunohistochemical analysis of bcl-2, bax and mcl-1 expression in prostate cancers
48. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
49. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
50. Hypersensitivity of human testicular tumors to etoposide induced apoptosis is associated with functional p53 and a high bax:bcl-2 ratio
51. Expression and regulation of bcl-2, bcl-X1 and bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia
52. Mutant p53 protein, bcl-2/bax ratio and apoptosis in paediatric acute lymphoblastic leukemia
53. A p53 and apoptotic independent role for p21waf1 in tumor response to radiation therapy